MatsukiyoCocokara & Co. (3088)

Name: MatsukiyoCocokara & Co. (3088) — histórico de demonstrações financeiras
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.

Healthcare · Wall Street (EUA) · Última atualização: 2026-09-30

MatsukiyoCocokara & Co. operates and manages chain stores, drug stores, and insurance dispensing pharmacies in Japan. The company is involved in franchise business development and product supply to franchisees, as well as management support services. It offers its products under the nake and RECiPEO brand names. MatsukiyoCocokara & Co. was founded in 1932 and is headquartered in Tokyo, Japan.

Números-chave

Capitalização de mercado: JPY 958 billion
Receita (exercício encerrado em 2026-03-31): JPY 1.12T
Lucro líquido: JPY 55.8B
Margem bruta: 35.2%
Margem líquida: 5.0%

Ver gráficos interativos e demonstrações completas → Modelo de avaliação (DCF) →

Demonstração de resultados anual

Demonstração de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Receita total	JPY 1.12T	JPY 1.06T	JPY 1.02T	JPY 951.2B	—
Lucro bruto	JPY 393.8B	JPY 372.2B	JPY 354.1B	JPY 329.3B	—
Resultado Operacional (EBIT)	JPY 84.9B	JPY 82.1B	JPY 75.7B	JPY 62.3B	—
Resultado líquido	JPY 55.8B	JPY 54.7B	JPY 52.3B	JPY 40.5B	—

Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.

Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de 3088. /companies/us/3088

Empresas semelhantes

As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.

English version →Todas as ações

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.